Table of Content - Global Dupuytrens Disease Market

Dupuytren's disease is a condition that affects the palmar fascia - the fibrous layer of tissue that lies underneath the skin and above the tendons, nerves, blood vessels, and bones in the palm and fingers. In patients with Dupuytren's disease, the fascia thickens and contracts (shortens) over time. The fascia may pull on the fingers during this process, causing them to be forced inward, toward the palm. This may make it difficult or impossible to fully straighten the fingers, resulting in what is known as a "Dupuytren's contracture." In some people, a worsening Dupuytren's contracture can interfere with hand function, making it difficult to perform daily activities. When this occurs, there are non-surgical and surgical treatment options available to help slow the progression (worsening) of the disease and improve motion in the affected fingers. The cause of Dupuytren contracture is unknown. The condition tends to run in families. It is more common in men than in women. Dupuytren contracture gets worse slowly, over years. The condition begins with a firm lump in the palm of the hand. This lump can be painful or painless. Over time, the lump can extend into a hard cord under the skin and up into the finger. This cord tightens and pulls the finger toward the palm, sometimes severely.

Market Dynamics:

The increasing prevalence of Dupuytren's disease is expected to drive the growth of the global Dupuytren’s disease market over the forecast period. For instance, according to data published in October 2022 by Cision US Inc., a public relations and earned media software company and services provider, an estimated 14 million people are affected by Dupuytren's disease every year in North America.

Key features of the study:

This report provides an in-depth analysis of the global Dupuytren’s disease market, and provides market size (US$ Bn ) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global Dupuytren’s disease market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Endo International Plc, Bristol-Meyers Squibb Company, Spear Pharmaceuticals, GSK Plc., AstraZeneca, Hikma Pharmaceuticals Plc, LEO Pharma A/S, Fresenius Kabi AG, Bayer AG, Novartis AG, Pfizer Inc., Nantong Jinghua Pharmaceutical Co., Ltd., and Actiza Pharmaceutical Pvt. Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global Dupuytren’s disease market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Dupuytren’s disease market

Detailed Segmentation:

Global Dupuytren’s Disease Market Segmentation, By Disease Type:
- Type I
- Type II
- Type III
Global Dupuytren’s Disease Market Segmentation, By Type:
- Diagnosis
  - Physical Examination
  - X-ray
- Treatment
  - Surgery
  - Radiation Therapy
  - Needle Aponeurotomy
  - Steroid Shot
  - Enzyme Injection
  - Occupational Therapy
  - Others
Global Dupuytren’s Disease Market Segmentation, By End User:
- Hospitals
- Clinics
- Academic & Research Institute
- Others
Global Dupuytren’s Disease Market Segmentation, By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profile:
- Endo International Plc
- Bristol-Meyers Squibb Company
- Spear Pharmaceuticals
- GSK Plc.
- AstraZeneca
- Hikma Pharmaceuticals Plc
- LEO Pharma A/S
- Fresenius Kabi AG
- Bayer AG
- Novartis AG
- Pfizer Inc.
- Nantong Jinghua Pharmaceutical Co., Ltd.
- Actiza Pharmaceutical Pvt. Ltd.

Table of Contents

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Dupuytren’s Disease , By Disease Type
  - Market Dupuytren’s Disease , By Type
  - Market Dupuytren’s Disease , By End User
  - Market Dupuytren’s Disease , By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
    - Increasing prevalence of Dupuytren’s disease
  - Restraints
    - High cost of treatment
  - Opportunities
    - Emerging economies
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER’s Analysis
- Merger and Acquisition Scenario
Global Dupuytren’s Disease Market – Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
Global Dupuytren’s Disease Market, By Disease Type, 2018-2030, (US$ Bn)
- Introduction
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, 2019 – 2030
  - Segment Trends
- Type I
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
- Type II
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
- Type III
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Global Dupuytren’s Disease Market, By Type, 2018-2030, (US$ Bn)
- Introduction
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, 2019 – 2030
  - Segment Trends
- Diagnosis
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
    - Physical Examination
    - X-ray
- Treatment
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
    - Surgery
    - Radiation Therapy
    - Needle Aponeurotomy
    - Steroid Shot
    - Enzyme Injection
    - Occupational Therapy
    - Others
Global Dupuytren’s Disease Market, By End User, 2018-2030, (US$ Bn)
- Introduction
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, 2019 – 2030
  - Segment Trends
- Hospitals
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
- Clinics
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
- Academic & Research Institute
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Global Dupuytren’s Disease Market, By Region, 2018-2030, (US$ Bn)
- Introduction
  - Market Share Analysis, By Country, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, For Country, 2019 – 2030
  - Country Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
  - Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
    - U.S.
    - Canada
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
  - Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
  - Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
    - China
    - India
    - Japan
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
  - Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Middle East
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
  - Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
  - Market Size and Forecast, By Country/Region, Y-o-Y Growth and By Country/Region, 2018 - 2030, (US$ Bn)
    - North Africa
    - Central Africa
    - South Africa
Competitive Landscape
- Endo International Plc
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Bristol-Meyers Squibb Company
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Spear Pharmaceuticals
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- GSK Plc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- AstraZeneca
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Hikma Pharmaceuticals Plc
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- LEO Pharma A/S
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Fresenius Kabi AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Bayer AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Novartis AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Pfizer Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Nantong Jinghua Pharmaceutical Co., Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Actiza Pharmaceutical Pvt. Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Analyst Views
Section
- Research Methodology
- About us

*Browse 35 market data tables and 31 figures on "Global Dupuytren’s Disease Market” - Global forecast to 2030

View Our Licence Options

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail
Request Discount